Indapta Therapeutics

Indapta Therapeutics company information, Employees & Contact Information

Explore related pages

Indapta Therapeutics email format Indapta Therapeutics management contacts

Related company profiles:

Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.

Company Details

Employees
22
Address
Seattle & Houston , Us
Industry
Biotechnology
Website
https://indapta.com/
Keywords
in multiple myeloma and drug development. We are encouraged that Sanofi appreciated the differentiated profile of IDP-023.
HQ
Seattle & Houston
Competitors
Outpace Bio, Akamis Bio, Citryll, Tune Therapeutics, Andelyn Biosciences, Atara Biotherapeutics, Shinobi Therapeutics, Tr1X, Umoja Biopharma, Sangamo Therapeutics, Inc..
Looking for a particular Indapta Therapeutics employee's phone or email?

Indapta Therapeutics Questions

News

UH Tech Bridge Community Member Indapta Therapeutics Advances Clinical Trials with $22.5M Funding - University of Houston

UH Tech Bridge Community Member Indapta Therapeutics Advances Clinical Trials with $22.5M Funding University of Houston

Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments - Business Wire

Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments Business Wire

Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program - Business Wire

Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program Business Wire

FDA Clears Indapta Therapeutics’ IND for Cell Therapy IDP-023 in Progressive Multiple Sclerosis - NeurologyLive

FDA Clears Indapta Therapeutics’ IND for Cell Therapy IDP-023 in Progressive Multiple Sclerosis NeurologyLive

SITC 2024 preview – late-breakers for Marengo and Indapta | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

SITC 2024 preview – late-breakers for Marengo and Indapta | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

FDA Fast Tracks IDP-023 for Non-Hodgkin Lymphoma and Myeloma - Targeted Oncology

FDA Fast Tracks IDP-023 for Non-Hodgkin Lymphoma and Myeloma Targeted Oncology

Indapta Therapeutics lands $22.5 million for cancer-fighting clinical trials - The Business Journals

Indapta Therapeutics lands $22.5 million for cancer-fighting clinical trials The Business Journals

Indapta Therapeutics Presents Clinical and Preclinical Data of Allogenic Natural Killer Cell Therapy at Society for Immunotherapy of Cancer Meeting - Business Wire

Indapta Therapeutics Presents Clinical and Preclinical Data of Allogenic Natural Killer Cell Therapy at Society for Immunotherapy of Cancer Meeting Business Wire

Indapta snags $50M financing and signs on former Juno exec as CEO - Fierce Biotech

Indapta snags $50M financing and signs on former Juno exec as CEO Fierce Biotech

Indapta Therapeutics Announces FDA Clearance of IND for Phase 1 Trial of IDP-023 for Progressive Multiple Sclerosis - Business Wire

Indapta Therapeutics Announces FDA Clearance of IND for Phase 1 Trial of IDP-023 for Progressive Multiple Sclerosis Business Wire

Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer - Business Wire

Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer Business Wire

Companies like Indapta Therapeutics

Tune Therapeutics logo - Similar company to Indapta Therapeutics

Tune Therapeutics

80
Atara Biotherapeutics logo - Similar company to Indapta Therapeutics

Atara Biotherapeutics

171
Citryll logo - Similar company to Indapta Therapeutics

Citryll

32
Shinobi Therapeutics logo - Similar company to Indapta Therapeutics

Shinobi Therapeutics

37
Umoja Biopharma logo - Similar company to Indapta Therapeutics

Umoja Biopharma

201
Tr1X logo - Similar company to Indapta Therapeutics

Tr1X

39
Outpace Bio logo - Similar company to Indapta Therapeutics

Outpace Bio

70
Akamis Bio logo - Similar company to Indapta Therapeutics

Akamis Bio

37
Andelyn Biosciences logo - Similar company to Indapta Therapeutics

Andelyn Biosciences

270
Sangamo Therapeutics, Inc. logo - Similar company to Indapta Therapeutics

Sangamo Therapeutics...

267

Top Indapta Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant